Received by email:

File: THC BioMed Intl - Press Release GMP (00943581-4x9DEBD).doc




THC BIOMED INTL LTD.
P.O. Box 20033 Towne Centre
Kelowna, B.C. V1Y 9H2
www.thcbiomed.com

THC Receives Good Manufacturing Practice ("GMP") Certification

THC - CSE         THCBF - OTC                TFHC - F
Vancouver, British Columbia - (February 22, 2018) THC BioMed Intl Ltd. (CSE: THC), ("THC" or the "Company") announces 
--->that it has received Good Manufacturing Practice ("GMP") certification for the production of Marijuana Plants and drie
--->d Marijuana.
THC has been assessed and meets the requirements of GOOD MANUFACTURING PRACTICE under the Codex Alimentarius Commissio
--->n, Recommended International Code of Practices, General Principles of Food Hygiene, CAC/RCP 1-1969, Rev. 4 (2003) for 
--->the production of Marijuana Plants, dried Marijuana (Propagation, Growing, Harvesting, Drying, Curing and Packaging).
"This certification is significant. It recognizes our high standards and now paves the way for THC BioMed Internationa
--->l to export its products into international markets. We are excited to begin the process of exporting our products to 
--->Europe and other markets," said John Miller, President and CEO of THC, "We have begun the process of strengthening our
---> international presence. The international cannabis market displays strong signs of growth and signals indicate a stro
--->ng demand for high-grade cannabis products internationally."
"Our expansion in anticipation of the recreational cannabis market is on target and we expect to introduce an addition
--->al 10 cannabis production rooms within the next few weeks," said Mr. Miller.
About THC
THC is an ACMPR Licensed Producer and Canada's largest supplier of legal Cannabis Genetics. THC is on the leading edge
---> of scientific research and the development of products and services related to the medical cannabis industry. Managem
--->ent believes THC is well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com  
President and CEO:
John Miller
THC Biomed Intl Ltd. 
T: 1-844-THCMEDS
E: info@thcbiomed.com
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the acc
--->uracy of the contents of this release. 
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, conc
--->erning the business of THC.  Forward-looking information is based on certain key expectations and assumptions made by 
--->the management of THC. In some cases, you can identify forward-looking statements by the use of words such as "will," 
--->"may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "cont
--->inue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or simi
--->lar expressions.  Although THC believes that the expectations and assumptions on which such forward-looking informatio
--->n is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give
---> no assurance that they will prove to be correct.  Forward-looking statements contained in this press release are made
---> as of the date of this press release and include that:  (a) THC will export its products into international markets, 
--->(b) THC will export its products to Europe and other markets, (c) there will be a strong demand for high-grade cannabi
--->s products internationally, (d) THC will introduce another 10 production rooms within the next few weeks, and, (e) THC
---> will be in the forefront of this rapidly growing industry. 
THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new 
--->information, future events or results or otherwise, other than as required by applicable securities laws.